SCHERING CORPORATION et al v. MYLAN PHARMACEUTICALS INC. et al > Summary
Court Case Number 2:10-cv-03085
Filing Date Jun 16, 2010
Termination Date Sep 10, 2010
Court New Jersey District Court
Status Statistical Closing
Defendant
Plaintiff Attorneys
8MSP Corporation
Attorney Name: Cristina Baragona
Lowenstein Sandler
Schering Corporation
Attorney Name: Cristina Baragona
Lowenstein Sandler
MSP Corporation
Attorney Name: Douglas Scott Eakeley
Lowenstein Sandler
Schering Corporation
Attorney Name: Douglas Scott Eakeley
Lowenstein Sandler
MSP Corporation
Attorney Name: Jason E. Halper
Lowenstein Sandler
Schering Corporation
Attorney Name: Jason E. Halper
Lowenstein Sandler
MSP Corporation
Attorney Name: Donald A. Robinson
Robinson Miller
Schering Corporation
Attorney Name: Donald A. Robinson
Robinson Miller
Defendant Attorneys
6Viatris Inc.
Attorney Name: Arnold B. Calmann
Saiber
Viatris Inc.
Attorney Name: Arnold B. Calmann
Saiber
Viatris Inc.
Attorney Name: Jakob Benjamin Halpern
Saiber
Viatris Inc.
Attorney Name: Jakob Benjamin Halpern
Saiber
Viatris Inc.
Attorney Name: Jeffrey Soos
Saiber
Viatris Inc.
Attorney Name: Jeffrey Soos
Saiber
Counter Defendant
6MSP Corporation
Attorney Name: Cristina Baragona
Lowenstein Sandler
Schering Corporation
Attorney Name: Cristina Baragona
Lowenstein Sandler
MSP Corporation
Attorney Name: Douglas Scott Eakeley
Lowenstein Sandler
Schering Corporation
Attorney Name: Douglas Scott Eakeley
Lowenstein Sandler
MSP Corporation
Attorney Name: Jason E. Halper
Lowenstein Sandler
Schering Corporation
Attorney Name: Jason E. Halper
Lowenstein Sandler
Counter Claimant
3Viatris Inc.
Attorney Name: Arnold B. Calmann
Saiber
Viatris Inc.
Attorney Name: Jakob Benjamin Halpern
Saiber
Viatris Inc.
Attorney Name: Jeffrey Soos
Saiber
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| RE037721 | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents | May 28, 2002 |
| 05846966 | Combinations of hydroxy-substituted azetidinone compounds and HMG CoA Reductase Inhibitors | Dec 8, 1998 |
